The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection

Vaccine. 2017 Feb 22;35(8):1110-1112. doi: 10.1016/j.vaccine.2017.01.022. Epub 2017 Jan 22.

Authors

Parker A Small Jr¹, Brendan J Cronin²

Affiliations

¹ University of Florida College of Medicine and UF Emerging Pathogens Institute, United States. Electronic address: Smallgroup2@aol.com.
² University of California San Diego School of Medicine, United States.

PMID: 28118937
DOI: 10.1016/j.vaccine.2017.01.022

No abstract available

Keywords: ACIP; Influenza; SLIV; Test negative case control; Vaccine.

MeSH terms

Advisory Committees*
Bias*
Humans
Immunization Programs
Influenza Vaccines / therapeutic use*
Influenza, Human / prevention & control*
Public Health Surveillance
Research Design*
Vaccines, Attenuated

Substances

Influenza Vaccines
Vaccines, Attenuated